BioCentury
ARTICLE | Clinical News

BSD Medical to start Phase I/II study

April 25, 2000 7:00 AM UTC

BSDM said it will start a U.S. Phase I/II trial combining hyperthermia with liposome-encapsulated doxorubicin to treat ovarian cancer. ...